Caitong International Asset Management Co., LTD Dr Reddys Laboratories LTD Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 40 shares of RDY stock, worth $542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 40
-0.0%
Holding current value
$542
Previous $632,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RDY
# of Institutions
265Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$155 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$153 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$136 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$128 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$76.1 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.25B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...